Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Hugo measured Gene Rank description expected final
Results: HTML CSV LaTeX
Showing element 1 to 50 of 3206 in total
Hugo: 

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.000173011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3206\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.7865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.000219976\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.000178236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3204\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ATLASTIN; GUANYLATE-BINDING PROTEIN 3. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.81025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.000219977\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0174991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1916\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHETHASE 2 (PAPS SYNTHETHASE 2) (PAPSS 2) (SULFURYLASE KINASE 2) (SK2) (SK 2) [INCLUDES: SULFATE ADENYLYLTRANSFERASE (EC 2.7.7.4) (SULFATE ADENYLATE TRANSFERASE) (SAT) (ATP-SULFURYLASE); ADENYLYLSULFAT\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0754368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.231970338\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0193287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
MASPIN PRECURSOR (PROTEASE INHIBITOR 5). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0871461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2217965\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0194204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
SERPIN B11. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0875599\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.221795594\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0199772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CYTOPLASMIC ANTIPROTEINASE 2 (CAP2) (CAP-2) (PROTEASE INHIBITOR 8) (SERPIN B8). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0900703\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.221795642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0202703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2773\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
DJ570F3.6 (NOVEL PROTEIN SIMILAR TO LYSOPHOSPHOLIPASE II (LYPLA2)). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.100647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201399942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.02137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1731\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0901539\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237039108\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0214576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1540\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
DJ1099D15.1 (PUTATIVE DNAJ PROTEIN). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0887019\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241906881\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0217565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2541\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.101375\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214614057\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0240826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2533\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 2-4; KERATIN ASSOCIATED PROTEIN 2.4. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.112137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760516\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.024834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17 BETA-HYDROXYSTEROID DEHYDROGENASE. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.105517\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23535544\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0249741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2532\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 1.5. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0250043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3024\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
SYNBINDIN (TRS23 HOMOLOG) (HEMATOPOIETIC STEM/PROGENITOR CELL PROTEIN 172) (HSPC172) (PTD009) (CGI-104). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.209553\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.119322081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0250957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
"KERATIN, ULTRA HIGH-SULFUR MATRIX PROTEIN A (UHS KERATIN A) (UHS KERA). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214761155\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.02527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2666\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
NEURAL CELL ADHESION MOLECULE L1 PRECURSOR (N-CAM L1) (CD171 ANTIGEN). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209233775\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0255653\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
2590\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
DC11 PROTEIN. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.120086\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.212891594\vspace{3pt}}}\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
2592\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HEPATITIS C VIRUS CORE-BINDING PROTEIN 6; CERVICAL CANCER ONCOGENE 3. \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0258656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 1-3; KERATIN ASSOCIATED PROTEIN 1.3. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760999\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0258973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2375\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
THIAMIN PYROPHOSPHOKINASE 1; MOUSE THIAMIN PYROPHOSPHOKINASE HOMOLOG; THIAMINE PYROPHOSPHOKINASE. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.220048603\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0259096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
820\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
"MYOSIN LIGHT CHAIN 1, EMBRYONIC MUSCLE/ATRIAL ISOFORM (PRO1957). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0991465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261326421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0260682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2534\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4.3 (FRAGMENT). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.121383\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214759892\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.027225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2077\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 6 (PROTEIN KE2). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22912038\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0274494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1854\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117581\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233450983\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0275157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PRESENILIN-LIKE PROTEIN 2 (EC 3.4.99.-) (SPPL2A PROTEIN). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117865\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233450982\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0275762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1647\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.11537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23902401\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0280741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2529\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-10; KERATIN ASSOCIATED PROTEIN 4.10. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.130722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214761861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0281805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1003\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HUNTINGTIN INTERACTING PROTEIN E; HUNTINGTIN INTERACTOR PROTEIN E. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.110551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.254909499\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0285187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
659\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
SECRETED MODULAR CALCIUM-BINDING PROTEIN 1. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.106766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.267114063\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0286746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
504\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ENIGMA PROTEIN; LIM DOMAIN PROTEIN. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.104626\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.274067631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.028817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3187\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
"PROTEIN PHOSPHATASE 1, REGULATORY (INHIBITOR) SUBUNIT 14C; SEROLOGICALLY DEFINED BREAST CANCER ANTIGEN NY-BR-81; PKC-POTENTIATED PP1 INHIBITORY PROTEIN. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.772261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.037315105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.029603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2002\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.128294\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230743449\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0296502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
745\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
BA508N22.1 (HSPC025) (FRAGMENT). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26449777\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0298281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
827\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PUTATIVE ANKYRIN-REPEAT CONTAINING PROTEIN. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.114163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261276421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.030828500000000002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2413\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.141189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.218349163\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
0.0308447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1481\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0.126946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.242974966\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0308655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2978\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C6 (HOX-3C) (HHO.C8) (CP25). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.221164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559332\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0310375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
811\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
BRAIN PROTEIN 16. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261549028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0310799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2983\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-A4 (HOX-1D) (HOX-1.4). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.222701\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.13955887\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0311872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2976\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C4 (HOX-3E) (CP19). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.223469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139559402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0312313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2866\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HEPATOMA-DERIVED GROWTH FACTOR-RELATED PROTEIN 2. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.165297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.188940513\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0312821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3049\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) GAMMA-5 LIKE SUBUNIT. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.293231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.10668074\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.031325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2088\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.13696\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228716414\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
0.0313747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2723\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0.1519\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.206548387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0314375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2528\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-2; KERATIN ASSOCIATED PROTEIN 4.2. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.146383\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21476196\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.031639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1423\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
NUCLEAR RECEPTOR CO-REPRESSOR/HDAC3 COMPLEX SUBUNIT TBLR1 (TBL1- RELATED PROTEIN 1). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.129724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24389473\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0320499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
POLY (ADP-RIBOSE) GLYCOHYDROLASE. \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.138898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230744143\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0321572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
752\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
LIPOPOLYSACCHARIDE-RESPONSIVE AND BEIGE-LIKE ANCHOR PROTEIN (CDC4-LIKE PROTEIN) (BEIGE-LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.121579\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264496336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0322794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1099\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PHOSPHOGLYCERATE MUTASE 1 (EC 5.4.2.1) (EC 5.4.2.4) (EC 3.1.3.13) (PHOSPHOGLYCERATE MUTASE ISOZYME B) (PGAM-B) (BPG-DEPENDENT PGAM 1). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.128445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.251309121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0331615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PRESENILIN-LIKE PROTEIN 1 (EC 3.4.99.-) (SPPL2B PROTEIN). \vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.142049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.233451133\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/